Merck to acquire Terns Pharmaceuticals for $6.7 billion

March 25, 2026 6:45 AM

Merck (NYSE: MRK) announced it will acquire Terns Pharmaceuticals Inc. (NASDAQ: TERN) for $53.00 per share in cash, representing an ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found